Actuate Therapeutics, Inc. Common stock (ACTU) stock forecast · $49.0M cap
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
This ACTU forecast page states what the cached financials imply — not a price target and not a guarantee. Actuate Therapeutics, Inc. Common stock outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for ACTU yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for ACTU, so this page does not invent a growth rate.
ACTU currently screens at market cap $49.0M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ACTU 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ACTU stock page.
Not investment advice.